top of page

Research Accomplishments

Ian has an impressive portfolio of publications, book chapters, and abstracts that showcase his extensive research and expertise in his field. Throughout his career, he has contributed significantly to academic discourse, reflecting his commitment to advancing knowledge and understanding.

Publications, Book Chapters & Abstracts 

Publications

  1. Baldwin I C, Elderkin T D 1995. CVVH in Intensive Care: Nursing Perspectives. New Horizons; 3(4):738-747.

  2. Baldwin I. 1997. Training Management and Credentialling for CRRT in Critical Care. American Journal of Kidney Diseases, Vol 30(5) S4.S112-116.

  3. Baldwin I C, Bridge N P, Elderkin T D. 1998:Nursing Issues, Practices, and Perspectives for the Management of Continuous Renal Replacement Therapy in the Intensive Care Unit. Critical Care Nephrology. 1309-1327. Kluwer Publishing Co, Netherlands.

  4. Baldwin I, Beckmann U, Shaw L, Morrison A 1998.  Australian Incident Monitoring Study in Intensive Care: Local unit review meetings and report management. Anaesthesia & Intensive Care, 26(3):294-297.

  5. Baldwin I and Heland M 2000. Incidence of cardiac dysrhythmias in patients during pulmonary artery catheter removal after cardiac surgery. May June. Heart and Lung. Vol. 29 No. 3.

  6. Baldwin I, Tan H K , Bridge N, and Bellomo R. 2000. A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration. Renal Failure. 22(3) 297-306.

  7. Baldwin I, Bridge N, Merrony N, et al. 1996. IV pump-controlled ultrafiltrate in CVVH : digital values versus measured volume and relationship to ultrafiltrate pressure. Australian Critical Care. 9 (1) 22-23 Abstract.

  8. Baldwin I., Bridge N., Heland M. et al. 1996. The effect of heparin administration site on extracorporeal circuit life during continuous venovenous haemofiltration. Australian Critical Care. Vol 9. No 1:22 Abstract.

  9. Baldwin I, BridgeN, Heland M. et al. 1996. The effect of filter configuration on extracorporeal circuit life during continuous veno-venous haemofiltration. Australian Critical Care. Vol 9. No 1: 22 Abstract

  10. Baldwin I , Bellomo R and Bridge N 1997. A prospective analysis of circuit life in continuous veno  venous hemofiltration with heparin anticoagulation using thromboelastography (TEG). Blood Purification, 15 : 140 Abstract

  11. Baldwin I and Bellomo R. 2001 Blood flow reduction associated with nursing care activities during continuous renal replacement therapy. Blood Purification. 19: 329 Abstract

  12. Baldwin I. CRRT : Keeping Pace with Changes in Technology and Technique. 2002 Blood Purification. 20;269-274.

  13. Baldwin I, Bellomo R, and Koch B. A technique for the monitoring of blood flow during continuous hemofiltration. Intensive Care Med 2002. 28 :1361-1364.

  14. Baldwin I , Tan HK, Bridge N, Bellomo R. Possible strategies to prolong circuit life during hemofiltration: three controlled studies. Renal Failure, 2002 Nov. 24 (6):839-48

  15. Baldwin I and Bellomo R. Sustained low efficiency dialysis in the ICU. International Journal of Intensive Care. 2002. Winter, pp. 177 – 187.

  16. Hart G K, Baldwin I C, Ford J, Gutteridge G ; Adverse Incident Reporting in Intensive Care, 1994. Anaesthesia & Intensive Care 22:556-561.

  17. Beckmann U, Baldwin I, Hart G.K., Runciman W.B. 1996. Australian Incident Monitoring Study in Intensive Care: AIMS-ICU. An analysis of the first year of Incident Reporting. Anaesthesia & Intensive Care, 24(3) 320-329.

  18. Beckmann U, West L.F. Groombridge G.J., Baldwin I, Hart G.K., Clayton D.G., Webb R.K., Runciman W.B. 1996. Australian Incident Monitoring Study in Intensive Care : AIMS-ICU. The development and evaluation of a voluntary anonymous incident reporting system in Intensive Care. Anaesthesia & Intensive Care, 24(3) 314-319.

  19. Bellomo R, Baldwin I, and Ronco C. High Volume Hemofiltration. Current Opinion in Critical Care. 2000 Vol. 6 (6):442-445.

  20. Bellomo R, Baldwin I and Ronco C. 2000 Rationale for extracorporeal blood purification therapies in sepsis. Vol 6 (6) :446-450.

  21. Beckmann U, Baldwin I, Durie M, Morrison A, Shaw L. 1998. Problems associated with nursing staff shortage : An analysis of the first 3600 incident reports submitted to the Australian Incident Monitoring Study ( AIMS-ICU). Anaesthesia & Intensive Care, 26(4) 396-400.

  22. Bellomo R, Baldwin I, Cole L, Ronco C. 1998. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney International. Vol. 53 s66 s182-s185.

  23. Bernard G , Vincent J L, Laterrie P F et. al. 2001 Efficacy and safety of recombinant human activated protein C for severe sepsis. (Investigator) The New England Journal of Medicine. No. 10 Vol. 344 pg. 699 – 709.

  24. Cole L, Bellomo R and Baldwin I. 1998 A randomized, prospective, cross over study of the hemodynamic effects of high volume hemofiltration in patients with septic shock. Blood purification. 16 : 113. Abstract.

  25. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. 2001. High- volume haemofiltration in human septic shock. Intensive Care Medicine. Vol. 27 No. 6 pp 978-986.

  26. Tan H K, Baldwin I, Bellomo R. 2000. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Medicine. 26 : 1652-1657

  27. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P, Ronco C, Everard P.Cytokine Removal with a Large Pore Cellulose Triacetate Filter: An Ex-vivo Study. Int J Artif Organs 2002; 25: 27-32

  28. Reiter K, D’Intini V, Bordoni V, Baldwin I, Bellomo R, Tetta C, Brendolan A, Ronco C. 2002. High volume hemofiltration in Sepsis. Theoretical basis and practical application. Nephron Oct; 92(2):251-8.

  29. Boyle M and Baldwin I. Introduction to an alternative view of acid base balance. The strong ion difference or Stewart Approach.  Australian Critical Care. 2002. 15(1):14-20

  30. Bellomo R, Baldwin I, Ronco C. High Volume Hemofiltration. Contributions in Nephrology. Basal Karger, 2001, vol. 132, 375-382

  31. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P.  Super high flux hemofiltration: a new technique for cytokine removal.  2002 Critical Care Medicine. 28 : 651 655

  32. Uchino S, Bellomo R, Morimatsu H, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P, Morgera S, Neumayer H, and Goelhl H.  Cytokine Dialysis: An Ex Vivo Study.  2002. 48:650-653. ASAIO Journal.

  33. Bellomo R, Baldwin I, Fealy N. Prolonged Intermittent renal Replacement Therapy in the Intensive Care Unit. 2002  Critical Care and resuscitation. 4:281 – 290.

  34. Fealy N, Baldwin I, Bellomo R. The effect of circuit down time on uraemic control during continuous veno-venous haemofiltration.  2002 Critical Care and Resuscitation 4: 266 – 270.

  35. Han Kim Tan, Nicholas Bridge, Ian Baldwin and Rinaldo Bellomo. 2002. An ex-vivo evaluation of vascular catheters for continuous hemofiltration. Renal Failure. Vol. 24. No. 6, pp. 755 - 762.

  36. Louise Cole, Rinaldo Bellomo, Ian Baldwin, Matthew Hayhoe, Claudio Ronco. The impact of lactate-buffered high volume hemofiltration on acid-base balance.  Intensive Care Medicine 29: 1113-1120.  2003

  37. S Uchino, Fealy N, Baldwin I, Morimatsu H, Bellomo R 2003. "Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control" Nephron Clinical Practice, Vol. 94, No. 4,  pp 94 – 98.

  38. WCR Lee, S Uchino, Fealy N, Baldwin I, Panagiotarapoulos S, Goehl H, Morgera L, HH Neumayer, Bellomo R 2003. B2 Microglobulin clearance with super high flux hemodialysis ; An  ex vivo study. Journal of Artificial Organs. 26. 8 723 – 727

  39. WCR Lee, S Uchino, Fealy N, Baldwin I, Panagiotarapoulos S, Goehl H, Morgera L, HH Neumayer, Bellomo R 2004. Super high flux hemodialysis at high dialysate flows : An ex vivo assessment. Journal of Artificial Organs. 27 (1) pp.24-28.

  40. Baldwin I, Bellomo R and Koch W. 2004. Blood Flow reductions during Continuous Renal Replacement Therapy and Circuit Life.  Intensive Care Medicine. 30: 2074-2079.

  41. Baldwin I and Bellomo R 2004. The relationship between blood flow, access catheter and circuit failure during CRRT; a practical review. Contributions to Nephrology, vol. 144. pp. 203-213.

  42. Bellomo R, Naka T and Baldwin I. 2004. Intravenous fluids and acid base balance.  Contributions to Nephrology, vol. 144, pp 105- 118.

  43. T Naka, Baldwin I, Bellomo R, Fealy N, and Wan L. 2004. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. International Journal of Artificial organs. Vol. 27. No. 5. pp. 380 – 387.

  44. Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer H H and Bellomo R. 2005. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis ; a case report. Critical Care, vol. 9 No. 2. R90 – R95.

  45. Naka T, Egi M, Bellomo R, Cole L, French C, Wan L, Fealy N, Baldwin I. 2005 Low dose citrate continuous-venous hemofiltration (CVVH) and acid base balance. The International Journal of Artificial Organs. Vol. 28. No. 3. pp. 222-228.

  46. Naka T, Egi M, Bellomo R, Cole L, French C, Botha J, Wan L, Fealy N and Baldwin I. 2005. Commercial low citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting. Anaesthesia and Intensive Care. 33: 601-608.

  47. Ronco C, Ricci Z, Bellomo R, Baldwin I, Kellum J. 2005 Management of fluid balance in CRRT: A technical approach. The International Journal of Artificial Organs. Vol. 28. No. 8 pp. 765-776.

  48. Palevsky P M, Baldwin I, Davenport A, Goldstein S, Paganini E. 2005. Renal replacement therapy and the kidney: minimising the impact of renal replacement therapy on recovery of acute renal failure. Current Opinion in Critical Care. Dec. 11(6) 548-554.

  49. Egi M, Naka T, Bellomo R, Cole L, French C, Trethewy C, Wan L, Langenberg C C, Fealy N, Baldwin I. 2005 A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration. The Journal of Artificial Organs. Vol. 28. no. 12. pp. 1211-1218.

  50. Fealy N, Baldwin I and Boyle M. 2005. The molecular adsorbent recirculating system (MARS). A therapy for the treatment of liver failure; review and case study. Australian Critical Care. Vol. 18. No. 3. pg. 96-102

  51. Baldwin I and Leslie G. 2006 . Support of Renal Function. Chapter 13 in ACCCN’s Critical Care Nursing. Elliot D, Aitken L, Chaboyer W, Editors. Elsevier Pub. Mosby Co, Sydney.

  52. Jones D,  Baldwin I, McIntyre T, Story D, Mercer I, Miglic A, Goldsmith D and   Bellomo R. Nurses attitudes to a medical emergency team service in a teaching hospital. Quality and Safety Health Care, 2006; 15; 427-432.

  53. Fealy N, Baldwin I, Johnstone M J, Egi M, Bellomo R. A pilot randomised controlled cross over study comparing regional heparinisation to regional citrate anticoagulation in patients receiving continuous veno venous hemofiltration : affect on filter life. 2007. International Journal of Artificial Organs,  Vol. 30,  No. 4 pp. 301-307.

  54. Bashaw S, Baldwin I, Fealy N, Bellomo R. 2007 Fluid Balance Error in Continuous Renal Replacement Therapy: A Technical Note.  International Journal of Artificial Organs. Vol. 30 No. 5 pp. 435-440.

  55. Baldwin I, Naka T, Koch B, Fealy N Bellomo R: 2007 A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Medicine Vol. 33. 830 – 835.

  56. M Haase, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Morgera S, Goehl H, Storr M,  Boyce N, Neumayer H H. B2 – microglobulin removal and plasma albumin levels with high cut-off hemodialysis. International journal of artificial organs. Vol. 30 No. 5, 2007. pp. 385-392.

  57. Baldwin I. 2007 Factors affecting  circuit patency and filter life. In Contributions to Nephrology Vol. 156. pp. 178-184. C Ronco, R Bellomo, J Kellum editors. Basel, Karger.

  58. Baldwin I. 2007 Is there a need for a nurse emergency team for continuous renal replacement therapy ?  in Contributions to Nephrology Vol. 156. pp. 191-196. C Ronco, R Bellomo, J Kellum editors. Basel, Karger.

  59. Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Davenport P, Morgera S, Goehl H, Storr M, Boyce N and Neumayer Hans-Hellmut. 2007. Hemodialysis membrane with a high molecular-weight cut off and cytokine levels in sepsis complicated by acute renal failure: A phase 1 Randomized trial. American Journal of Kidney diseases, Vol. 50 No. 2 pp. 296-304.

  60. Jones D, M Egi, Baldwin I, Bellomo R. 2004. A pilot study of the effect  of altering airway pressure on systolic pulse pressure variation in the systemic and pulmonary arterial circulations. Critical Care and Resuscitation. 6: 167-174.

  61. Jones D, Baldwin I, Bellomo R. 2004. A technique for the determination of systolic pressure variation in the systemic and pulmonary arterial circulations. Critical Care and Resuscitation. 6: 204-208.

  62. Egi M, Naka T, Bellomo R,  Langenberg C, W Li, Fealy N, Baldwin I. 2008 The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. The Journal of Artificial Organs. Vol. 31. No. 3. pp. 228-236.

  63. Haase M, Bellomo R, Morgera S Baldwin I,  Boyce N. 2007. High cut-off membranes in septic acute renal failure. A systematic review. The Int. Journal of Artificial Organs. Vol. 30. No. 12. pp. 1031-1041.

  64. Jones D, McIntyre T, Baldwin I, Mercer I, Kattula A and Bellomo R. The medical emergency team and end-of-life-care: a pilot study.  Critical care and Resuscitation. Vol. 9. Number 2. June  2007.

  65. Haase M, Bellomo R,  Baldwin I, Haase-Fielitz A, Storr  M, Krause B, Boyce N, Svobodova S, Li W, Bagshaw S M, Warrillow S, Langenberg C, Morgera S. 2008. The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxemia. The Int. Journal of Artificial Organs. Vol. 31. No. 8. pp. 722- 729.

  66. Naka T, Egi M, Bellomo R, Baldwin I, Fealy N, Wan L. 2008. Resistance of vascular access catheters for continuous renal replacement therapy: An ex vivo evaluation. The International Journal of Artificial Organs. Vol. 31. No. 10. pp. 905 – 909.

  67. Baldwin I and Fealy N. 2009 Nursing for renal replacement therapies in the Intensive Care Unit: historical, educational, and protocol review. Blood Purification. 27: 174 – 181.

  68. Baldwin I and Fealy N. 2009 Clinical nursing for the application of renal replacement therapies in the Intensive Care Unit. Seminars in Dialysis. Vol. 22 No. 2. pp 189 – 193.

  69. Rose L, Baldwin I and Crawford T. 2010 The use of bed-dials to maintain recumbent positioning for critically ill mechanically ventilated patients (The RECUMBENT study) : Multicentre before and after observational study.  International Journal of Nursing Studies.

  70. In Byung Kim, Fealy N, Baldwin I, Bellomo R. 2010 Premature circuit clotting due to likely mechanical failure during Continuous Renal Replacement Therapy. Blood Purification. 30:79 – 83

  71. Rose L, Baldwin I, Crawford T, and Parke R. 2010 Semi recumbent positioning in ventilator dependant patients: A multicentre observational study. American Journal of Critical Care.

  72. Boyle M and Baldwin I. 2010 Understanding the Continuous Renal Replacement Therapy circuit for Acute Renal failure support; A quality issue in the Intensive Care Unit. AACN Advanced Critical Care Vol. 21 No. 4 pp. 365 - 75

  73. Freitag E, Edgecombe G, Baldwin I, Cottier B, Heland M. 2010 Determination of body weight and height measurement for critically ill patients admitted to the intensive Care unit: A quality improvement project. Australian Critical Care. 23; 97 – 207.

  74. Anticoagulation for renal replacement therapy: different methods to improve safety.

  75. Contrib Nephrol.;165:251-62. Oudemans-van Straaten HM, Fiaccadori E, Baldwin I. 2010

  76. In Byung, Nigel Fealy, Ian Baldwin, Rinaldo Bellomo. 2011 Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access. Blood Purification; 31: 42-46

  77. Chee BC, Baldwin IC, Shahwan-Akl L, Fealy NG, Heland MJ, Rogan JJ. 2011

  78. Evaluation of a radial artery cannulation training program for intensive care nurses: A descriptive, explorative study. Aust Crit Care. Jan 4.

  79. In Byung Kim,  Nigel Fealy,  Ian Baldwin,  Bellomo R. 2011 Circuit start during continuous renal replacement  therapy in vasopressor dependent patients: the impact of a slow blood flow protocol. Blood Purification. 32:1-6

  80. In Byung Kim, Bellomo R, Fealy N, Baldwin I. 2011 A pilot study of the epidemiology and associations of pulse pressure variations in cardiac surgery patients. Critical care and Resuscitation.. Vol 13. No. 1 17 – 23

  81. Farrell M, Baldwin I, Fealy N. 2011 Post Graduate Nurses’ Use of Personal Digital Assistants in Critical Care. Electronic Journal of Health Informatics. Vol. 6(3): e24

  82. Eastwood G M, Reade M C, Peck L, Baldwin I, Considine J and Bellomo R. 2012 Critical care nurses opinion and self reported practice of oxygen therapy: A survey. Australian Critical Care 25, pp. 23-30

  83. Kim I B, Prowle J, Baldwin I, Bellomo R. 2012 Incidence, risk factors and outcome associations of intra-abdominal hypertension in critically ill patients. Anaesthesia and Intensive Care. 40: 1; pp. 79 -89

  84. Eastwood G M, Peck L, Bellomo R, Baldwin I, and Reade M C 2012 A questionnaire survey of critical care nurses’ attitudes to delirium assessment before and after introduction of the CAM-ICU. Australian Critical Care

  85. Schneider A G, Baldwin I, Freitag E, Glassford N, and Bellomo R. 2012 Estimation of fluid status changes in critically ill patients: Fluid balance chart or electronic bed weight  ? Australian Critical Care. 745e7 – 745 e12

  86. Baldwin I and Leslie G. 2012 . Support of Renal Function. Chapter 18 in ACCCN’s Critical Care Nursing. Elliot D, Aitken L, Chaboyer W, Editors. Elsevier Pub. Mosby Co, Sydney.2nd Edn.

  87.  Eastwood GM, Peck L, Young H, Bailey M, Reade MC, Baldwin I, Bellomo R. 2011                   Haemodynamic Impact of a slower pump speed at start of continuous renal replacement therapy in critically Ill adults with acute kidney injury: a prospective before-and-after study.   Blood Purification. 2012;33(1-3):52-8. Epub 2011 Dec 15.

  88. Chua HR, Baldwin I, Fealy N, Naka T, Bellomo R. 2012 Amino Acid Balance with Extended Daily Diafiltration in Acute Kidney Injury. Blood Purif. 2012 May 31;33(4):292-299. [Epub ahead of print]

  89. Brown R, Baldwin I, Rasmussen R. Assisting ICU training management with Virtual Worlds. ICU Management. 2012 (2)

  90. Ku Lisa, Weinberg L, Seevanayagam S, Baldwin I, Opdam H and Doolan L. Massive air embolism from continuous  electromechanical dissociation in a cardiac surgical patient. Critical Care and Resuscitation. 2012; 14: 2: 154-158.

  91. Chua H R, Baldwin I, Bailey M, Subramaniam A,  Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. Journal of Critical Care 2012. Dec;27(6):744.e7-744.e15.

  92. Baldwin I, Fealy N, Carty P, Boyle M, Inbyung K, Bellomo R. Bubble trap chamber clotting during continuous renal replacement therapy: Vertical versus horizontal blood flow entry. Blood Purification. 2012; 34: 213-218.

  93. Brown R, Rasmussen R, Baldwin I, Wyeth P. Design and implementation of a virtual world training simulation of ICU first hour handover processes. Australian Critical Care 2012 25, 178 – 187

  94. McIntyre T, Taylor C, Eastwood G M, Jones D, Baldwin I, Bellomo R. A survey of ward nurses attitudes to the intensive care nurse consultant service in a teaching hospital.  Australian Critical Care 2012 25, 100 – 109

  95. Chua H R, Baldwin I, Ho L, Collins A, Allsep H and Bellomo R. 2012 Biochemical effects of phosphate containing replacement fluid for continuous veno-venous hemofiltration. Blood Purification. 2012 Dec 12;34(3-4):306-312

  96. Chua HR, Schneider AG, Baldwin I, Collins A, Ho L Bellomo R. 2013 Phoxilium vs Hemosol-BO for continuous renal replacement therapy in acute kidney injury. J Crit Care. Oct;28(5):884.e7-14

  97. Karalapillai D, Baldwin I, Dunnachie G, Knott C, Eastwood G, Rogan J, Carnell E, and Jones D. 2013 Improving communication of the daily care plan in a teaching hospital intensive care unit. Critical Care and Resuscitation. 15: 97-102

  98. McIntyre T, Taylor C, Reade M, Jones D and Baldwin I. 2013 Characteristics and outcomes of patients subject to intensive care nurse consultant review in a teaching hospital. Critical Care and Resuscitation. Vol. 15. No. 1 134-141

  99. Jeong Chu  K, Cruz D, Francesco F, Manish K, Catarina T, Baldwin M, Baldwin I, Federico N, Ji Hyun K, Eungtaek K, Hee C Kim, Ronco C. 2013 Effects of dialysate flow configurations in continuous renal replacement therapy on solute removal: Computational Modelling. Blood Purification. 35: 106 – 111.

  100. Paton E and Baldwin I. 2014 Plasma Exchange in the Intensive Care Unit ; A 10 year retrospective audit. Australian Critical Care. Vol 27. No. 3 pp. 139 – 144.

  101. Zhang L, Baldwin I, Zhu G, Tanaka A and Bellomo R. 2015 Automated electronic monitoring of circuit pressures during continuous renal replacement therapy : a technical report. Crit care and Resuscitation. Vol. 17 No. 1 March.

  102. Fealy N, Aitken L, du Toit E, Baldwin I. Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care units.  Critical Care and Resuscitation 2015; 17: 83 – 91.

  103. Topple M, Ryan B, McKay R, Blythe D, Rogan J, Baldwin I and Jones D. Features of an Intensive Care based Medical Emergency Team nurse training program in a university teaching hospital. 2015 Australian Critical Care.

  104. Baldwin I, Baldwin M, Fealy N, Neri M, Garzotto F, Kim J C, Giuliani A, Basso F, Nalesson F, Brendolan A, and Ronco C. 2016 Concurrent versus counter-current dialysate flow during CVVHD. A comparative study for creatinine and urea removal. Blood Purification. 41:171-176.

  105. Cerdá J, Baldwin I, Honore P, M, Villa G, Kellum J, A, Ronco C, Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy. Blood Purif.  2016;42:248-265

  106. Topple  M, Ryan B, Baldwin I, McKay R, Blythe D, Rogan J, Radford S and Jones D. 2016 The Austin Health MET nurse investigators. Intensive and Critical Care Nursing. 32. 12 - 19

  107. Sprogis S K, Currey J, Considine J, Baldwin I, and Jones D. 2017 Physiological antecedents and ward clinician responses before activating medical emergency team activation. Critical Care and Resuscitation. Vol. 19, No. 1 March. Pp. 50 – 56.

  108. Schneider A, Baldwin I and Souweine B. 2017. What’s new: Prevention of acute dialysis catheter-related infection. Intensive Care Medicine. May. 2017

  109. Fealy N, Aitken L, du Toit E, Bailey M, and Baldwin I. Evaluation of urea and creatinine change during continuous renal replacement therapy: effect of blood flow rate.  Critical Care and Resuscitation 2018; 20 (1): 41 – 47.

  110. Healy, C., Baldwin, I., Currey, J., & Driscoll, A. (2018). A randomised controlled trial to determine the effectiveness of a radial arterial catheter dressing. Critical Care And Resuscitation, (1), 61.

  111. Fealy N, Aitken L, du Toit E, Lo S, Baldwin I. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial. Crit Care Med. 2017;45(10):e1018-e25.

  112. Baldwin I, Jones D, Carty P, Fealy N. 2020 Continuous Renal Replacement Therapy without Anticoagulation: Top Ten Tips to Prevent Clotting. Blood Purification. 49(4):490-495.

  113. Califano A M, Bitker L, Baldwin I, Fealy N, Bellomo R. 2020.  Circuit survival during continuous venovenous hemodialysis versus continuous venovenous hemofiltration. Blood Purification. 49(3) 281-288. 

  114. Bellomo R, Baldwin I, Ronco C, Kellum J A. 2021. ICU-Based Renal Replacement Therapy. SCCM Journal, March , Vol. 49 No. 3. Pg. 406-418.

  115. Baldwin I, Mottes T. Acute kidney injury and continuous renal replacement therapy: A nursing perspective for my shift today in the intensive care unit. Semin Dial. 2021;34(6):518-29.

  116. Juncos LA, Chandrashekar K, Karakala N, Baldwin I. Vascular access, membranes and circuit for CRRT. Semin Dial. 2021;34(6):406-15.

  117. Thummaporn N, Yanase F, Eastwood G, Baldwin I, Bellomo R. 2021 Extracorporeal ammonia clearance for hyperammonia in critically ill patients.: A scoping review. Blood Purification; 50: 453-561.

  118. Caleb Fisher, Ian Baldwin, Nigel Fealy, Thummaporn Naorungroj, Rinaldo Bellomo. Ammonia clearance with different continuous renal replacement therapy techniques in patients with liver failure. Blood Purification. DOI:10.1159/000521312 Jan 2022

  119. Baldwin I, Todd S. Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations. J Clin Apher. Aug;37(4):397-404.2022.

  120. Thummaporn N, Baldwin I, Eastwood G, Bellomo R. 2023 The effect of the AN69ST100 versus oXiris membrane on filter life during CRRT for non-anticoagulated liver failure patients.  Int. Journal of Artificial Organs. Apr.; 46(4): 209-214.

  121. Furukawa T, Lankadeva Y, Baldwin I C, Chen P, Hood S, May C, Bellomo R. Vancomycin and Gentamicin removal with the HA 380 Cartridge during experimental Hemoadsorption. Blood Purification, Oct. 2023. DOI: 10.1159/000534108

  122. Baldwin I, Maeda A, Bellomo R, See E. Haematocrit monitoring and blood volume estimation during continuous renal replacement therapy. Aust Crit Care. 2024 Jan 19:S1036-7314(23)00193-5. doi: 10.1016/j.aucc.2023.11.005.

  123. Baldwin IC, McKaige A. 2024 Fluid balance in Continuous Renal Replacement Therapy: prescribing, delivering and review. Blood Purif. 53(7):533-540 Feb 20.

  124. Ankawi G, Bagshaw SM, Bellomo R, Baldwin I, Basu R, Bottari G, Cantaluppi V, Clark W, De Rosa S, Forni LG, Fuhrman D, Goldstein S, Gomez H, Husain-Syed F, Joannidis M, Kashani K, Lorenzin A, Mehta R, Murray PT, Murugan R, Ostermann M, Pannu N, Premuzic V, Prowle J, Reis T, Rimmelé T, Ronco C, Rosner M, Schneider A, See E, Soranno D, Villa G, Whaley-Connell A, Zarbock A. Hemoadsorption: Consensus report of the 30th Acute Disease Quality Initiative workgroup. Nephrol Dial Transplant. 2024 Apr 15:gfae089. doi: 10.1093/ndt/gfae089. Epub ahead of print. PMID: 38621759.

  125. Akinori Maeda, Ian Baldwin, Sofia Spano, Anis Chaba, Atthaphong Phongphithakchai, Nuttapol Pattamin, Yukiko Hikasa, Rinaldo Bellomo, Emily See; Relative Blood Volume Monitoring during Continuous Renal Replacement Therapy (CRRT): A Prospective Observational Study. Blood Purif 2024; https://doi.org/10.1159/000540838

  126. Chivot M, Baldwin I, Deniel G, David G, Eastwood GM, Richard JC, Bellomo R, Bitker L. CaCl2-Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation. Blood Purif. 2024 Aug 30:1-11. doi: 10.1159/000541059. Epub ahead of print. PMID: 39217973.

  127. Ian Baldwin, Jian Wen Chan, Stuart Downs, Connor Palmer; e-Prescribing, Charting, and Documentation for Continuous Renal Replacement Therapy: A Green Intensive Care Unit and Nephrology Initiative. Blood Purif 2024; https://doi.org/10.1159/000541487​

Books & Book Chapters

  1. Bellomo R, Baldwin I, Ronco C, Golper T. 2001. Atlas of Hemofiltration. W.B.Saunders, London. Author for chapters; 4, 5, 6, 7, 15, 17.

  2. Kellum J, Bellomo R, Ronco C. 2010. Continuous Renal Replacement Therapy. Oxford Press, New York. Author for chapters; 3, 7, 12, 15, 16, 17, 30, 31.

  3. Kellum J, Bellomo R, Ronco C. 2024. Continuous Renal Replacement Therapy. Oxford Press, New York. Author for chapters; 8, 13, 17, 18, 19, 32.

  4. Baldwin I and Leslie G  1st Ed 2007, 2nd 2012, 3rd 2015 . Chapter 18.  In ACCCN’s Critical Care Nursing, Support of  Renal Function.  Elsevier, Sydney.

  5. Baldwin I and Dirkes S, 4th Ed. 2019. Chapter 18.  In ACCCN’s Critical Care Nursing, Support of  Renal Function.  Elsevier, Sydney.

  6. Baldwin I, 2024, 5th Ed. Chapter 18.  In ACCCN’s Critical Care Nursing, Support of  Renal Function.  Elsevier, Sydney.

  7. Baldwin I  2015. Chapter  21.  Operational and Nursing  aspects. In Acute Nephrology for  the Critical Care Physician. Springer  International. H M Oudemans – van Straaten editor.

  8. Critical Care Nephrology. Editions. : 1st : (Chapt. 237, 245), 2nd: (Chapt. 237, 245)  , and 3rd 2019 (Chapt. 162, 169)  Authors.  Ronco C, Bellomo R, Kellum J, Ricci Z. Elsevier, Philadelphia.

Conference Abstracts

  1. Baldwin I, Heland M, Turner A. 1997. The incidence of cardiac arrhythmias during pulmonary artery catheter removal in post operative cardiac surgery patients.

  2. Baldwin I, Gleeson P, Kissane T, and Bellomo R. 1997. High volume haemofiltration

  3. (6 L/hour U.F.) for septic shock : Nursing care and management.

  4. 3. Cole L, Bellomo R, Baldwin I. 1997. A randomised, prospective, cross-over study of the hemodynamic effects of high volume hemofiltration in patients with septic shock.

  5. 4. Baldwin I. 1997. Continuous renal replacement therapy in ICU : have recent advances got it right and what does the future hold ?

  6. Baldwin I. 1997. Vascular access management for CRRT.

  7. Baldwin I. 1998. Blood flow maintenance in CRRT : Maintenance and assessment.

  8. Baldwin I and Bellomo R. 1999. Inadequate blood flow during continuous renal replacement therapy.

  9. Baldwin I and Beckmann U. 1999. Complications associated with continuous renal replacement therapy.

  10. Q.A.  for CRRT, Nursing management for CRRT in Australia, Machines and technical aspects of the CRRT circuit: 5th International Conference on Continuous Renal Replacement Therapies, San Diego, USA, March.,2000.

  11. 1.Vascular access, membrane and circuit. 2. Keeping pace with changes in technology and technique. 6th International Conference on Continuous Renal Replacement Therapies, San Diego, USA, March.,2001.

  12. Clinical Use of Drotrecogin alfa (activated): A Nursing Perspective. 8th World Congress of Intensive and Critical  Care  Medicine. Sydney, 2001

  13. Vascular access management for CRRT. 8th World Congress of Intensive and Critical  Care  Medicine. Sydney.

  14. Ian Baldwin, Nigel Fealy, Rinaldo Bellomo. 2002.  SLOW Low-Efficiency diafiltration with On line fluids production in the ICU setting, Perth. Australian ASM – ICU.

  15. Ian Baldwin I, Fealy N, Naka T, Bellomo R, Koch B;  2003 Extended daily dia-filtration (EDDf) for acute renal failure in the ICU setting. Cairns. Australian  28th ASM – ICU, 2003.

  16. Invited presentation. SLEDD and hybrid renal replacement therapies. Cairns. Australian  28th ASM – ICU, 2003.

  17. Invited presentation. CRRT for ARF : Opinions and evidence, a practical perspective. Cairns. Australian  28th ASM – ICU, 2003.

  18. Invited presentation. Hemofiltration fluids: Which one should we use ? Cairns. Australian  28th ASM – ICU, 2003.

  19. Acute Renal Failure and Renal Replacement Therapy in Intensive Care ; 1st Malaysian Society of Critical Care and Anaesthesiology, Kuala Lumpur, Malaysia, Oct 2003.

  20. Incident Monitoring in Intensive Care, 1st Malaysian Society of Critical Care and Anaesthesiology, Kuala Lumpur, Malaysia, Oct 2003.

  21. Nursing Education in Intensive Care, 1st Malaysian Society of Critical Care and Anaesthesiology, Kuala Lumpur, Malaysia, Oct 2003.

  22. Renal Replacement Therapy in Intensive Care Nursing. La Trobe University Research Symposium. School of Nursing and Midwifery. Dec. 2003

  23. Vascular access, membrane and circuit : workshop. 9th International meeting on CRRT, San Diego, California. USA, 2004.

  24. Monitoring and treating complications of CRRT ; Nursing symposium. 9th International meeting on CRRT, San Diego, California. USA, 2004.

  25. SLED Vs CRRT ; comparison of therapies workshop ; 9th International meeting on CRRT, San Diego, California. USA, 2004.

  26. The role of the ICU Nurse in Acute RRT, 3rd International Course on Critical Care Nephrology, Vincenza, Italy, June 2004.

  27. The basics of extracorporeal circulation,  3rd International Course on Critical Care Nephrology, Vincenza, Italy, June 2004.

  28. Trouble shooting strategies in CRRT, 3rd International Course on Critical Care Nephrology, Vincenza, Italy, June 2004.

  29. CRRT : Indications, prescriptions, nutrition and drug clearance, International Paediatric Nephrology Association, 13th Congress,  Adelaide, Australia, 2004.

  30. SLED or CRRT, 2nd International Symposium on Critical Care Nephrology. Oct. 2004. Melbourne, Australia.

  31. The technology and rationale for on-line fluid replacement generation. 2nd International Symposium on Critical Care Nephrology. Oct. 2004. Melbourne, Australia.

  32. Nursing, training, fluids, machines, clotting and all that chaos. 2nd International Symposium on Critical Care Nephrology. Oct. 2004. Melbourne, Australia.

  33. Nursing standards and competency assessment for extracorporeal techniques. 10th International meeting on CRRT, San Diego, California. USA, 2005.

  34. Therapy Comparisons: SLED vs CRRT vs PD.  10th International meeting on CRRT, San Diego, California. USA, 2005.

  35. Enhancements in technology : What’s needed ? 10th International meeting on CRRT, San Diego, California. USA, 2005.

  36. Vascular access/Membrane and Circuit. 10th International meeting on CRRT, San Diego, California. USA, 2005.

  37. Therapy Comparisons: SLED vs CRRT. 3rd World congress of nephrology; Post congress satellite symposium. Penang, Malaysia. 1st-3rd July 2005.

  38. Daily dialysis in the ICU by ICU nurses, how and why ? The 6th Annual symposium on Critical Care Nursing. Aug. 5th 2005. Melbourne, Victoria.  Australian College of Critical Care Nurses.

  39. A pilot randomised controlled trial comparing CVVH and EDDf in critically ill patients : effect on fluid balance and costs.  Baldwin I, Naka T, Fealy N, Bellomo R, Koch W.  30th Australian  & New Zealand Annual Scientific Meeting on Intensive Care, Adelaide, Oct. 20-23rd, 2005

  40. A pilot randomised controlled trial comparing CVVH and EDDf in critically ill patients : azotaemia and acid base control.  Baldwin I, Naka T, Fealy N, Bellomo R, Koch W.  30th Australian  & New Zealand Annual Scientific Meeting on Intensive Care, Adelaide, Oct. 20-23rd.

  41. Daily dialysis in the ICU, why and how ? Baldwin I. The 7th Institute of Continuing Education Meeting. Melbourne, May 26th and 27th, 2006.

  42. Baldwin I, Haase M, Fealy N, Bellomo R. 2006 albumin and protein losses comparing super high-flux Dialysers with standard dialysers in septic shock-induced ARF. 31st  Australian  & New Zealand Annual Scientific Meeting on Intensive Care, Hobart, Oct. 13-15rd.

  43. Vascular access/Membrane and Circuit. 12th International meeting on CRRT, San Diego, California. USA, 2007.

  44. Organisational aspects of CRRT programs. 12th International meeting on CRRT, San Diego, California. USA, 2007.

  45. Diffusive clearance of cytokines in sepsis ? Fact or fantasy ?  12th International meeting on CRRT, San Diego, California. USA, 2007.

  46. Factors affecting circuit patency and filter life. Baldwin I. 4th  International Course on Critical Care Nephrology, Vincenza, Italy, June 2007.

  47. Is there a need for a nurse emergency team for CRRT.  Baldwin I. 4th  International Course on Critical Care Nephrology, Vincenza, Italy, June 2007.

  48. Management of the patient with ARF in the ICU. Victorian Regional critical Care meeting June, 2007  Bendigo. Vic.

  49. Overview for the management of Sepsis. Victorian Regional critical Care meeting June, 2007  Bendigo. Vic.

  50. Research and practise innovation for cardiac, renal and sepsis in the critically ill. Baldwin I. Qld. ACCCN meeting Cairns, Australia. July 2007.

  51. Overview of sepsis. Baldwin I. Qld. ACCCN meeting Cairns, Australia. July 2007.

  52. Incident reporting : ‘AIMS ICU’ Paper reports compared to ‘Riskman’ electronic reporting over two years. Baldwin I, Rogan J, Heland M, Hart GK. Austin Health Research Week, Oct. 08’ and Asia Pacific Critical Care Congress. ANZICS / ACCCN ASM Sydney, 2008.

  53. Evaluation of a Radial Arterial Line insertion program for Intensive Care Nurses.  John Rogan, Bee Choo Chee, Ian Baldwin, Nigel Fealy. Asia Pacific Critical Care Congress. ANZICS / ACCCN ASM Sydney, 2008

  54. Improving Outcomes in AKI: Its All About Nursing! 14th International meeting on CRRT, San Diego, California. USA, 2009.

  55. Competency Assessment in CRRT  14th International meeting on CRRT, San Diego, California. USA, 2009.

  56. Essentials for Developing, Nurturing and Growing a CRRT Program : Training and audit  14th International meeting on CRRT, San Diego, California. USA, 2009.

  57. Technology for RRT: Do We Have What We Need?  Special Panel Discussion  14th International meeting on CRRT, San Diego, California. USA, 2009.

  58. Vascular Access /Membrane and Circuit  14th International meeting on CRRT, San Diego, California. USA, 2009.

  59. Vascular access and blood flow mechanics during CRRT. Annual CRRT workshop, Singapore Society of Nephrology. Singapore  May 22nd 2010-09-02

  60. Anticoagulation in CRRT : Practices and pitfalls. Annual CRRT workshop, Singapore Society of Nephrology. Singapore May 22nd 2010-09-02

  61. Optimising RRT in the Intensive Care Unit.  ACCCN Vic 8th  Annual Symposium on Critical Care: Sebal Hotel, Melbourne, April 2010

  62. Circuit patency and filter life: A quality issue. 19th International Vicenza Course on Critical care Nephrology. June 2010.

  63. Citrate anticoagulation for CVVH: 19th International Vicenza Course on Critical care Nephrology. June 2010.

  64. A comparison of two extracorporeal CRRT circuit bubble trap chambers; vertical versus horizontal blood entry. ANZICS / ACCCN Intensive Care ASM 14th – 16th October 2010.

  65. Large RCT’s in RRT: What can be learned for nursing ? 16th International CRRT meeting. Feb. 22-25 2011 San Diego, California, USA.

  66. Learning and Monitoring clinical development in the ICU: Using ‘Avatar’  interactive software and Web based clinical experience portals.  16th International CRRT meeting. Feb. 22-25 2011 San Diego, California, USA.

  67. Large RCTs in RRT: What can be learned from  them ? August 18-20th 2011 Beijing, China 3rd Critical Care Medicine Forum of Peking University

  68. Anticoagulation in CRRT : Practices and pitfalls. August 18-20th 2011 Beijing, China 3rd Critical Care Medicine Forum of Peking University

  69. Biochemical effects of phosphate containing replacement fluid for continuous veno-venous haemofiltration. Chua H, Baldwin I, Bellomo R. The 36th Australian and New Zealand  Annual Scientific Meeting on  Intensive Care, Brisbane, October 13-15th , 2011.

  70. Comparison between fluid balance and changes in body weight in the critically ill. Schneider A, Baldwin I, Freitag E, Glassford N, Bellomo R. The 36th Australian and New Zealand  Annual Scientific Meeting on  Intensive Care, Brisbane, October 13-15th , 2011.

  71. No Touch waste fluid disposal during CRRT in the ICU. Baldwin I, Fealy N, Carty P, Kennedy P. The 36th Australian and New Zealand  Annual Scientific Meeting on  Intensive Care, Brisbane, October 13-15th , 2011.

  72. Fluids and fluid balance during CRRT. How far have we come ? (Invited breakfast presentation, sponsored by Baxter Health Care. The 36th Australian and New Zealand  Annual Scientific Meeting on  Intensive Care, Brisbane, October 13-15th , 2011.

  73. Learning in Critical care using Avatar and CEP software. Australian and New Zealand Clinical Trials group meeting (CTG) Noosa Heads, Qld. March 2012.

  74. Best Practice in Haemofiltration now. ACCCN ICE meeting, Melbourne, June 2012.

  75. Citrate and anticoagulation strategies in RRT. Renal Support in the Critically Ill, Melbourne, July  2012.

  76. CRRT – success and failure: past, present, future ? Renal Support in the Critically Ill, Melbourne, July  2012.

  77. Strategies for optimizing the CRRT circuit. 18th International conference on continuous renal replacement therapies. San Diego, California. USA. February 12th  – 15th, 2013.

  78. CRRT for the experienced user 2: Solutions, fluid removal, fluid balance, monitoring.  18th International conference on continuous renal replacement therapies. San Diego, California. USA. February 12th  – 15th, 2013.

  79. CRRT for the experienced user 3: Technique adjustments case studies. 18th International conference on continuous renal replacement therapies. San Diego, California. USA. February 12th  – 15th, 2013.

  80. patient Centred care in the ICU – The Team approach  18th International conference on continuous renal replacement therapies. San Diego, California. USA. February 12th  – 15th, 2013.

  81. Frequent clotting during CRRT: sources and solutions. ANZICS ACCCN  38th ASM Hobart, TAS Oct 2013

  82. Dialysate fluid flow in CVVHD: Does counter-current flow increase clearance for small solutes ?  ANZICS ACCCN  38th ASM Hobart, TAS Oct 2013

  83. Challenges in critical care nephrology nursing 2: Combined CRRT with ECMO, Pheresis, Sorbents, O.R. San Diego, California. USA. February 4th  – 7th, 2014.

  84. Challenges in critical care nephrology nursing 1: Patient assessment, preparation, therapy and monitoring. San Diego, California. USA. February 4th  – 7th, 2014.

  85. Research design and conduct. Nursing and pharmacy research. San Diego, California. USA. February 4th  – 7th, 2014.

  86. Nursing:  ensuring patient safety and quality for RRT in AKI. Training requirements, core curriculum, skills assessment. San Diego, California. USA. February 4th  – 7th, 2014.

  87. MET nurse tasks : A prospective  observational study. ANZICS quality and safety conference, Melbourne, Vic. July 2014.

  88. The Haemodynamic Effects of a fluid Bolus. Regional Critical care Conference,  Building on Excellence. Bendigo, April 17th and 18th. 2015.

  89. Teaching and Technology  : Regional Critical care Conference,  Building on Excellence. Bendigo, April 17th and 18th. 2015.

  90. Renal Support and Blood Purification : Regional Critical care Conference,  Building on Excellence. Bendigo, April 17th and 18th. 2015.

  91. CRRT from prescription to delivery. 33rd Vicenza course on nephrology, Vicenza, Italy June 9 – 12th, 2015

  92. Knott C, Baldwin I, Carty P. 2015 Evaluation of feasibility of a planned interprofessional workplace educational program in immediate post-cardiac surgical intensive care: ‘the role swap’.

  93. Nigel Fealy, Leanne Aitken, Eugene du Toit, Ian Baldwin. 2015 Blood flow rate and circuit life in continuous renal replacement therapy (crrt): a pilot randomised controlled trial.

  94. Zhang l, Tanaka A, Zhu G, Baldwin I, Eastwood GM, Bellomo R. 2015. Patterns and mechanisms of artificial kidney failure during continuous renal replacement therapy.

  95. Baldwin I  Singapore Society of Nephrology, Nursing Chapter, Oct 7th and 8th, 2016. Singapore.  Research, A Nursing Journey.

  96. Baldwin I  Singapore Society of Nephrology, Nursing Chapter, Oct 7th and 8th, 2016. Singapore.  Maintaining CRRT Circuit: Non Anticoagulation Strategies.

  97. Baldwin I  Singapore Society of Nephrology, Nursing Chapter, Oct 7th and 8th, 2016. Singapore.  Patient Monitoring, When should we be altered. ?

  98. An evaluation of a Smart Phone Application for education needs in post graduate intensive care nursing. Ms Julia De Marchi, A.Prof. Nigel Fealy, Mrs Paula Carty, Prof. Ian Baldwin.  ANZICS and ACCCN 41st ASM, Perth, Oct 2016

  99. Preserving circuit patency, Baldwin I. 36th Vicenza Course on AKI and CRRT. Vicenza, Italy, June 14th. 2018

  100. NURSE - Orders, Charting and Monitoring. 25th AKI and CRRT meeting, San Diego, Feb-March. 2019

  101. 3rd Asia Pacific AKI and CRRT Meeting. Kuala Lumpur, Malaysia.

  102.  Establishing and maintaining a Performance Improvement Program for RRT. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  103. Implementing Therapy Delivery Dose Adjustments, Fluid Balance. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  104. Integrating Multidisciplinary Support Team for CRRT Delivery. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  105. Monitoring. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  106. NURSE Track - Orders, Charting and Monitoring. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  107. Nursing Track – Therapy Monitoring and troubleshooting, Alarms, Therapy Discontinuation. 25th AKI and CRRT meeting, San Diego, Feb-March. 2020

  108. 4th Asia Pacific AKI and CRRT Meeting; Dec 2020 Bangkok, ‘Virtual Meeting’ due to COVID-19 travel restrictions. Nurse Track, Dec 12th Lecture : Principles of CRRT.

  109. 4th Asia Pacific AKI and CRRT Meeting; Dec 2020  Bangkok, ‘Virtual Meeting’ due to COVID-19 travel restrictions. Nurse Track, Dec 12th Lecture : Access, Membrane, Circuit.

  110. 4th Asia Pacific AKI and CRRT Meeting; Bangkok, Dec 2020  ‘Virtual Meeting’ due to COVID-19 travel restrictions. Nurse Track, Dec 12th Lecture : Developing quality measures for CRRT delivery.

  111. 4th Asia Pacific AKI and CRRT Meeting; Bangkok, Dec 2020  ‘Virtual Meeting’ due to COVID-19 travel restrictions. Nurse Track, Dec 12th Lecture : CRRT orders, prescribing, and programming.

  112.  4th Asia Pacific AKI and CRRT Meeting; Bangkok, Dec 2020  ‘Virtual Meeting’ due to COVID-19 travel restrictions. Nurse Track, Dec 12th Lecture : Connection to hybrid systems ; Blood purifiers, apheresis, ECMO.

  113. Implementing Therapy Delivery Dose Adjustments, Fluid Balance. 26th AKI and CRRT Virtual  meeting, San Diego, Feb-March. 2021

  114. Monitoring. 26th AKI and CRRT Virtual  meeting, San Diego, Feb-March. 2021

  115. Nursing Track – Therapy Monitoring and troubleshooting, Alarms, Therapy Discontinuation. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  116. Nursing Track – Patient Mobilisation and Rehab. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  117. Workshop D04 Managing patients with combined kidney and Liver  failure. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  118. Workshop B06 Can we achieve precision solute control with CRRT. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  119. Teaching and Training for CRRT – developing competency. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  120. Managing ALF with associated AKI and CRRT : The 5 ‘H’ approach. 26th AKI and CRRT Virtual meeting, San Diego, Feb-March. 2021

  121. Changes in intravascular volume  and cardiac output during RRT. 41st Vicenza course on AKI and CRRT. Vicenza Italy, June 12th -14th, 2023.

  122. Drug clearance in hemoadsorption – Vancomycin and others with Jafron - sorbents. 41st Vicenza course on AKI and CRRT. Vicenza Italy, June 12th -14th, 2023.

  123. Principles of CRRT. 5th APAC AKI CRRT Daegu, South Korea, Sept. 2023

  124. Access, Membrane, Circuit. 5th APAC AKI CRRT Daegu, South Korea, Sept. 2023

  125. Developing quality measures for CRRT. 5th APAC AKI CRRT Daegu, South Korea, Sept. 2023

  126. CRRT solute control and dynamic dosing. CRRT solute control and dynamic dosing.

  127. Paper to digital, e-prescribing and charting for CRRT during AKI in the ICU. 29th International CRRT and AKI meeting . San Diego, CA, USA. March 12th 2024.

  128. Knowing your circuit, alarms and other tricks for CRRT. 29th International CRRT and AKI meeting . San Diego, CA, USA. March 12th 2024.

  129. Team based management of CRRT : It takes a village. 29th International CRRT and AKI meeting . San Diego, CA, USA. March 14th 2024.Connectology with  hybrid systems ; ECMO, Apheresis, ECCOR.  29th International CRRT and AKI meeting . San Diego, CA, USA. March 14th 2024.

bottom of page